Best Practice Criteria for Pluripotent Stem Cell Lines
This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. Dr. Lyn Healy from the Francis Crick Institute gives a detailed overview of best practice criteria for pluripotent stem cell lines and provides practical advice about how to assess cell quality.
Publish Date:
April 20, 2020
Related Multimedia
-
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
Publish Date: November 01, 2019 -
Nature Research Round Table: Best Practices for the QC of Genome-Edited hPSC Lines - Panel Discussion
Publish Date: November 01, 2019 -
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019
Explore Our Products
-
Healthy Control Human iPSC Line, Female, SCTi003-A
Human pluripotent stem cell line, frozen -
cGMP, enzyme-free human pluripotent stem cell selection and passaging reagent -
Human Pluripotent Stem Cell Trilineage Differentiation qPCR Array
For characterization of hPSC trilineage differentiation to endoderm, mesoderm, and ectoderm germ layers -
Feeder-free, animal component-free culture medium for maintenance of human ES and iPS cells
